News Incentive schemes behind inhaler and edoxaban switching targets should be scrapped, say MPs In a report on the future of general practice, MPs said it was clear the current target and incentive system "is not having the desired effect on outcomes".…Published: 21 October 2022
Feature ‘I could not wait to get back into clinical pharmacy and seeing patients’ Kate Jenkins, practice pharmacist, The Practice of Health, Barry, Vale of Glamorgan…Published: 6 October 2022
News Some patients switched to edoxaban without being properly informed, pharmacists say Exclusive: Primary care pharmacists have revealed that patients are being switched to edoxaban without being informed or when it is not clinically appropriate.…Published: 31 August 2022
News Statins should not be stopped in older people owing to their benefits, say researchers People with lower cardiovascular disease risk who stopped taking statins aged 80 years lost 73% of their potential benefit if they took them for the rest of their lives, a modelling study has suggested.…Published: 25 August 2022
News Non-steroidal anti-inflammatory drugs linked with heart failure in patients with diabetes Researchers found that NSAID use in any period was linked with a 43% increased risk of subsequent hospitalisation for heart failure.…Published: 24 August 2022
Feature Edoxaban switching scheme: worth the risks? GP practices in England are being paid millions of pounds to switch up to a third of patients to edoxaban, currently the cheapest choice of anticoagulant for the NHS. However, switching is not always straightforward and there is speculation that patients will need to be switched again in the future.…Published: 27 July 2022
News Community pharmacies in England carry out more than 110,000 blood pressure checks in six months Community pharmacies also provided ambulatory blood pressure monitoring to nearly 5,000 patients.…Published: 23 June 2022
News NICE to approve icosapent ethyl for some high-risk cardiovascular patients The National Institute for Health and Care Excellence says 425,000 people with established cardiovascular disease could benefit from treatment with icosapent ethyl.…Published: 22 June 2022
News Deprivation and ethnicity linked with lower anticoagulation prescribing for atrial fibrillation, study reveals Researchers found that, compared with white people, black people were 22% less likely to be prescribed an oral anticoagulant and those from other ethnic minorities were 24% less likely.…Published: 14 June 2022
Feature Shifting the scales: a promising new era for weight-loss drugs With obesity rates continuing to rise, the need for pharmacological options to help patients safely lose weight is urgent, but there are several promising drugs on the horizon.…Published: 9 June 2022
